CVE:ACST

Acasti Pharma Inc. (ACST.V) Stock Forecast, Price & News

C$0.88

+0.07 (+8.64 %)

(As of 01/20/2021 01:45 PM ET)

Add

Compare

Today's Range

C$0.78

Now: C$0.88▼

C$0.91

50-Day Range

C$0.01

MA: C$0.48▼

C$0.86

52-Week Range

C$0.22

Now: C$0.88▼

C$1.29

Volume949,132 shs

Average Volume1.53 million shs

Market CapitalizationC$85.27 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat patients with hypertriglyceridemia; and TRILOGY that is in Phase III to evaluate the safety and efficacy of CaPre in patients with sHTG. The company was incorporated in 2002 and is headquartered in Laval, Canada.

Overall MarketRank^™

0.54 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Acasti Pharma Inc. (ACST.V).

2.7 Community Rank

Outperform Votes
Acasti Pharma Inc. (ACST.V) has received 132 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Acasti Pharma Inc. (ACST.V) has received 112 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Acasti Pharma Inc. (ACST.V) has received 54.10% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Acasti Pharma Inc. (ACST.V) and other stocks. Vote “Outperform” if you believe ACST will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ACST will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Acasti Pharma Inc. (ACST.V) does not currently pay a dividend.
Dividend Growth
Acasti Pharma Inc. (ACST.V) does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Acasti Pharma Inc. (ACST.V) insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Acasti Pharma Inc. (ACST.V) is -11.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Acasti Pharma Inc. (ACST.V) is -11.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Acasti Pharma Inc. (ACST.V) has a P/B Ratio of 8.70. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange CVE

Industry Biotechnology

Sub-IndustryN/A

SectorMedical

Current SymbolCVE:ACST

Previous SymbolCVE:APO

CUSIPN/A

CIKN/A

Webwww.acastipharma.com

Phone+1-450-6864555

Employees32

Debt

Debt-to-Equity Ratio1.34

Current Ratio3.66

Quick Ratio3.25

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowC$0.15 per share

Price / Cash Flow6.05

Book ValueC$0.09 per share

Price / Book9.57

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares96,893,000

Market CapC$85.27 million

Next Earnings DateN/A

OptionableNot Optionable

C$0.88

+0.07 (+8.64 %)

(As of 01/20/2021 01:45 PM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive ACST News and Ratings via Email

Sign-up to receive the latest news and ratings for ACST and its competitors with MarketBeat's FREE daily newsletter.

Acasti Pharma Inc. (ACST.V) (CVE:ACST) Frequently Asked Questions

How has Acasti Pharma Inc. (ACST.V)'s stock price been impacted by Coronavirus (COVID-19)?

Acasti Pharma Inc. (ACST.V)'s stock was trading at C$0.54 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ACST shares have increased by 63.0% and is now trading at C$0.88.
View which stocks have been most impacted by COVID-19.

What stocks does MarketBeat like better than Acasti Pharma Inc. (ACST.V)?

Wall Street analysts have given Acasti Pharma Inc. (ACST.V) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Acasti Pharma Inc. (ACST.V) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Acasti Pharma Inc. (ACST.V)'s key competitors?

Some companies that are related to Acasti Pharma Inc. (ACST.V) include Synairgen plc (SNG.L) (SNG), Neptune Wellness Solutions Inc. (NEPT.TO) (NEPT), ProMetic Life Sciences (PLI), IMV Inc. (IMV.TO) (IMV), Tiziana Life Sciences PLC (TILS.L) (TILS), Arix Bioscience plc (ARIX.L) (ARIX), Fennec Pharmaceuticals Inc. (FRX.TO) (FRX), Medicenna Therapeutics Corp. (MDNA.TO) (MDNA), Emblem (EMC), Bioventix PLC (BVXP.L) (BVXP), Resverlogix Corp. (RVX.TO) (RVX), Theratechnologies Inc. (TH.TO) (TH), Open Orphan plc (ORPH.L) (ORPH), Faron Pharmaceuticals Oy (FARN.L) (FARN) and Redx Pharma Plc (REDX.L) (REDX).
View all of ACST's competitors.

What other stocks do shareholders of Acasti Pharma Inc. (ACST.V) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Acasti Pharma Inc. (ACST.V) investors own include Matinas BioPharma (MTNB), Aurora Cannabis Inc. (ACB.TO) (ACB), SCYNEXIS (SCYX), Square (SQ), Nokia (NOK), Axsome Therapeutics (AXSM), Blink Charging (BLNK), Inovio Pharmaceuticals (INO), Okta (OKTA) and Tesla (TSLA).

Who are Acasti Pharma Inc. (ACST.V)'s key executives?

Acasti Pharma Inc. (ACST.V)'s management team includes the following people:

Ms. Janelle D' Alvise, Pres, CEO, Corp. Sec. & Director (Age 66, Pay $565.48k)
Dr. Pierre Lemieux, Co-Founder, COO & Chief Scientific Officer (Age 56, Pay $344.15k)
Mr. Brian D. Ford CPA, CA, Chief Financial Officer

What is Acasti Pharma Inc. (ACST.V)'s stock symbol?

Acasti Pharma Inc. (ACST.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ACST."

How do I buy shares of Acasti Pharma Inc. (ACST.V)?

Shares of ACST and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What is Acasti Pharma Inc. (ACST.V)'s stock price today?

One share of ACST stock can currently be purchased for approximately C$0.88.

How big of a company is Acasti Pharma Inc. (ACST.V)?

Acasti Pharma Inc. (ACST.V) has a market capitalization of C$85.27 million. Acasti Pharma Inc. (ACST.V) employs 32 workers across the globe.

What is Acasti Pharma Inc. (ACST.V)'s official website?

The official website for Acasti Pharma Inc. (ACST.V) is www.acastipharma.com.

How can I contact Acasti Pharma Inc. (ACST.V)?

Acasti Pharma Inc. (ACST.V)'s mailing address is 545 Prom du Centropolis Suite 100, LAVAL, QC H7T 0A3, Canada. The company can be reached via phone at +1-450-6864555.

This page was last updated on 1/20/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Acasti Pharma Inc. (ACST.V) Stock Forecast, Price & News

Adding

Adding

Adding Acasti Pharma Inc. (ACST.V)

MarketRank™

Overall MarketRank™